Articles By Marcus Johnson

91. GlaxoSmithKline Asking For Tougher Regulation On E-Cigarettes 2/26/2014

    Pharmaceutical giant GlaxoSmithKline is asking the EU for tougher regulation of E-Cigarettes.

92. Wisconsin Legislation Changes Coverage For Pill Forms Of Cancer Drugs 2/26/2014

    A new bill in the Wisconsin legislature would change the way that cancer drugs taken orally can be covered by insurance companies.

93. High Price Of Breast Cancer Drug In New Zealand Could Continue 2/21/2014

    In New Zealand, the high price of a breast cancer drug is causing concern among the government.

94. Drug Firm Cadence Bought By Mallinckrodt For $1.3 Billion 2/21/2014

    Irish drug company Mallinckrodt has come to terms with a purchase price on San Diego based firm Cadence Pharmaceuticals. The price has been reported at $1.3 billion. The deal gives Mallinckrodt control over Cadence’s line of specialty drugs, which were coveted.

95. Pfizer Faces Regulatory Action From Australian Government 2/21/2014

    Drug industry giant Pfizer is now facing regulatory action from the Australian government. The government’s competition regulator, the Australian Competition and Consumer Commission (ACCC) has said that Pfizer has illegally marketed the cholesterol drug Lipitor to Australian pharmacies, in direct violation of antitrust law.

96. Actavis Acquires Forest Laboratories For $25 Billion 2/21/2014

    Pharmaceutical giant Actavis confirmed on Tuesday that it had purchased Forest Laboratories for $25 billion in a deal that involved cash and stock. The deal would make Actavis a global producer of both generic and brand drugs. While Actavis has long focused on generic drugs, Forest has been successful with branded products such as Lexapro and Namenda.

97. PLOS ONE Science Journal Claims Drug Companies Ignore Poor 2/20/2014

    Last week, the Science Journal PLOS ONE released an online post where they heavily criticized pharmaceutical companies for reducing the amount of money allocated to research and development on drugs that could help those living in impoverished situations around the globe.

98. Generic Drug Companies Battle Proposed FDA Regulation 2/20/2014

    Generic drug companies sell the medications that ultimately reach the majority of Americans. Generic companies are being put at risk by a new proposed FDA regulation that would require them to warn patients of all potential health risks that their products carry.

99. Researchers Claim Children Exposed To More Dangerous Chemicals 2/20/2014

    Researchers claim that the recent surge in children diagnosed with ADHD, dyslexia, and autism are all related to an increase in exposure to dangerous chemicals. Researchers from the Harvard School of Public Health, as well as the Icahn School of Medicine, found that a number of neurotoxins can have negative effects on children and hamper their cognitive development.

100. Jazz Pharmaceuticals Spends 50 Million Euros On Ireland Manufacturing Plant 2/13/2014

     Jazz Pharmaceuticals has decided to invest 50 million euros in Ireland and build a manufacturing plant there that will include 50 new jobs for high skill workers. The manufacturing plant, expected to be completed in 2016, will sit on over 17 acres in Monksland.